News Focus
News Focus
Followers 19
Posts 834
Boards Moderated 0
Alias Born 09/14/2013

Re: Bngo post# 209583

Thursday, 07/07/2016 1:42:36 PM

Thursday, July 07, 2016 1:42:36 PM

Post# of 446529
He bought 27,880 shares at $0.355 and $0.345 today.
I also bought 27,888 shares at $0.355 today.

Can you HONESTLY tell me why you think Elite's SequestOx will not get approved when Pfizer's Embeda with ADT labeling has already been approved with similar technology?

SequestOx ADF will be approved...here is why I am confident of it and why I added 27,888 more shares today.

I am asking again for any solid rebuttal out there why the FDA would not approve SequestOx when it has already approved Embeda?

Has the FDA made any new rules or change the previous rules of the ADT approval process?

If the FDA has approved Pfizer's Embeda with an ADT labeling, then why wouldn't they approve Elite's SequestOx with similar Abuse Deterrent Technology?

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm419288.



FDA Approves Abuse Deterrent Labeling For EMBEDA® (Morphine Sulfate And Naltrexone Hydrochloride) Extended-Release (ER) Capsules CII

http://www.pfizer.com/news/press-release/press-release-detail/fda_approves_abuse_deterrent_labeling_for_embeda_morphine_sulfate_and_naltrexone_hydrochloride_extended_release_er_capsules_cii

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News